Literature DB >> 8045989

Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy.

A Porcellini1, I Ciullo, L Laviola, G Amabile, G Fenzi, V E Avvedimento.   

Abstract

Hyperfunctioning thyroid adenomas are clonal neoplasms with the intrinsic capacity of growing and differentiate independently of thyroid-stimulating hormone (TSH). We analysed the mRNA encoding thyrotropin receptor of 11 adenomas obtained by fine needle aspiration biopsy (FNAB) and found 7 mutants all located in three aminoacids clustered in the sixth transmembrane domain of the receptor. These mutations were somatic and specifically present in the tumour tissue. DNA sequence revealed that 80 to 90% of the mutations can be rapidly screened and identified by restriction enzyme analysis of the amplified cDNA obtained from the FNABs. The mutation Thr->Ile was introduced in the wild type receptor and expressed in mouse fibroblasts. These cells constitutively activate the transcription of a reporter gene under the control of cyclic AMP responsive element.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8045989     DOI: 10.1210/jcem.79.2.8045989

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

Review 1.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

Review 2.  Review: amino acid domains involved in constitutive activation of G-protein-coupled receptors.

Authors:  P J Pauwels; T Wurch
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

Review 3.  Molecular insights into TSH receptor abnormality and thyroid disease.

Authors:  D Russo; F Arturi; E Chiefari; S Filetti
Journal:  J Endocrinol Invest       Date:  1997-01       Impact factor: 4.256

4.  Thyroid autoantibody measurement by enzyme immunoassay.

Authors:  D C Stephen; N Thomas; R Selvakumar; M S Seshadri; A S Kanagasabapathy
Journal:  Indian J Clin Biochem       Date:  1997-12

5.  Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281-->isoleucine) in the extracellular domain of the thyrotropin receptor.

Authors:  P Kopp; S Muirhead; N Jourdain; W X Gu; J L Jameson; C Rodd
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

6.  Genetic analysis of the TSH receptor gene in differentiated human thyroid carcinomas.

Authors:  F Cetani; M Tonacchera; A Pinchera; R Barsacchi; F Basolo; P Miccoli; F Pacini
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

Review 7.  Controversies in thyroid pathology: the diagnosis of follicular neoplasms.

Authors:  Stefano Serra; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

8.  Genetics of papillary thyroid cancer initiation: implications for therapy.

Authors:  James A Fagin
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

Review 9.  Molecular biology of thyroid cancer initiation.

Authors:  G Riesco-Eizaguirre; P Santisteban
Journal:  Clin Transl Oncol       Date:  2007-11       Impact factor: 3.405

10.  A somatic gain-of-function mutation in the thyrotropin receptor gene producing a toxic adenoma in an infant.

Authors:  Brenda Kohn; Helmut Grasberger; Leslie L Lam; Alfonso Massimiliano Ferrara; Samuel Refetoff
Journal:  Thyroid       Date:  2009-02       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.